iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7500
+0.0500 (7.14%)
At close: Apr 23, 2025, 4:00 PM
0.7310
-0.0190 (-2.53%)
After-hours: Apr 23, 2025, 4:53 PM EDT
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $7.41 million as of April 23, 2025. Its market cap has increased by 0.08% in one year.
Market Cap
7.41M
Enterprise Value
5.05M
1-Year Change
0.08%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $7.41M, a decrease of -73.26%. That is a compound annual growth rate of -8.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2025 | 6.90M | -69.20% |
Dec 31, 2024 | 22.40M | 1,078.95% |
Dec 29, 2023 | 1.90M | -52.50% |
Dec 30, 2022 | 4.00M | -96.66% |
Dec 31, 2021 | 119.70M | -37.40% |
Dec 31, 2020 | 191.20M | 2,320.25% |
Dec 31, 2019 | 7.90M | -43.57% |
Dec 31, 2018 | 14.00M | -14.63% |
Dec 29, 2017 | 16.40M | -53.41% |
Dec 30, 2016 | 35.20M | -18.71% |
Dec 31, 2015 | 43.30M | -12.17% |
Dec 31, 2014 | 49.30M | 128.24% |
Dec 31, 2013 | 21.60M | -27.03% |
Dec 31, 2012 | 29.60M | 10.04% |
Dec 30, 2011 | 26.90M | -73.23% |
Dec 31, 2010 | 100.50M | 298.81% |
Dec 31, 2009 | 25.20M | -9.03% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 748.55B |
UnitedHealth Group | 397.09B |
Johnson & Johnson | 380.42B |
AbbVie | 305.11B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 228.50B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |